255
Views
143
CrossRef citations to date
0
Altmetric
Review

Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress

&
Pages 265-272 | Published online: 05 Mar 2009

References

  • YusufSSleightPPogueJBoschJDaviesRDagenaisGEffects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study InvestigatorsN Engl J Med2000342314515310639539
  • FensterBETsaoPSRocksonSGEndothelial dysfunction: clinical strategies for treating oxidant stressAm Heart J2003146221822612891188
  • McCordJMFridovichISuperoxide dismutase. An enzymic function for erythrocuprein (hemocuprein)J Biol Chem196924422604960555389100
  • ZhangMShahAMRole of reactive oxygen species in myocardial remodelingCurr Heart Fail Rep200741263017386182
  • TakimotoEKassDARole of oxidative stress in cardiac hypertrophy and remodelingHypertension200749224124817190878
  • FranciaPdelli GattiCBachschmidMMartin-PaduraISavoiaCMigliaccioEDeletion of p66shc gene protects against age-related endothelial dysfunctionCirculation2004110182889289515505103
  • TrineiMGiorgioMCicaleseABarozziSVenturaAMigliaccioEA p53–p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosisOncogene200221243872387812032825
  • KobayashiNDeLanoFASchmid-SchonbeinGWOxidative stress promotes endothelial cell apoptosis and loss of microvessels in the spontaneously hypertensive ratsArterioscler Thromb Vasc Biol200525102114212116037565
  • McNamaraDMHolubkovRPostavaLRamaniRJanoskoKMathierMEffect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failureCirculation2003107121598160212668492
  • GodfreyVChanSLCassidyAButlerRChoyAFardonTThe functional consequence of the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene in young healthy volunteersCardiovasc Drug Rev200725328028817919260
  • GriendlingKKMinieriCAOllerenshawJDAlexanderRWAngiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cellsCirc Res1994746114111488187280
  • HarrisonDGriendlingKKLandmesserUHornigBDrexlerHRole of oxidative stress in atherosclerosisAm J Cardiol2003913A7A11A
  • CingolaniHEPlastinoJAEscuderoEMMangalBBrownJPerezNGThe effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata StudyJ Card Fail200612749149816952781
  • ClelandJGFColettaAPClarkALClinical trials update from the Heart Failure Society of America meeting: FIX-CHF-4, selective cardiac myosin activator and OPT-CHFEur J Heart Fail20068776476617049305
  • WaringWSMcKnightJAWebbDJMaxwellSRLowering serum urate does not improve endothelial function in patients with type 2 diabetesDiabetologia200750122572257917928991
  • BerryCEHareJMXanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implicationsJ Physiol2004 16;555(Pt 3): 58960614694147
  • HancockJTSalisburyVOvejero-BoglioneMCCherryRHoareCEisenthalRAntimicrobial properties of milk: dependence on presence of xanthine oxidase and nitriteAntimicrob Agents Chemother200246103308331012234868
  • StevensCRMillarTMClinchJGKanczlerJMBodamyaliTBlakeDRAntibacterial properties of xanthine oxidase in human milkLancet2000356923282983011022933
  • PacherPNivorozhkinASzaboCTherapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinolPharmacol Rev20065818711416507884
  • ParksDAGrangerDNXanthine oxidase: biochemistry, distribution and physiologyActa Physiol Scand Suppl198654887993529824
  • CicoiraMZanollaLRossiAGoliaGFranceschiniLBrighettiGElevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathyAm Heart J200214361107111112075270
  • IchidaKAmayaYNodaKMinoshimaSHosoyaTSakaiOCloning of the cDNA encoding human xanthine dehydrogenase (oxidase): structural analysis of the protein and chromosomal location of the geneGene199313322792848224915
  • Della CorteEGozzettiGNovelloFStirpeFProperties of the xanthine oxidase from human liverBiochim Biophys Acta196919111641664309908
  • ZhangZBlakeDRStevensCRKanczlerJMWinyardPGSymonsMCA reappraisal of xanthine dehydrogenase and oxidase in hypoxic reperfusion injury: the role of NADH as an electron donorFree Radic Res19982821511649645392
  • PfefferKDHuecksteadtTPHoidalJRXanthine dehydrogenase and xanthine oxidase activity and gene expression in renal epithelial cells. Cytokine and steroid regulationJ Immunol19941534178917978046245
  • UsudaNReddyMKHashimotoTRaoMSReddyJKTissue specificity and species differences in the distribution of urate oxidase in peroxisomesLab Invest19885811001113336202
  • WilkinsonSRPrathalingamSRTaylorMCHornDKellyJMVitamin C biosynthesis in trypanosomes: A role for the glycosomeProc Natl Acad Sci U S A200510233116451165016087875
  • HilleRMasseyVStudies on the oxidative half-reaction of xanthine oxidaseJ Biol Chem198125617909090956894924
  • GuercioliniRSzumlanskiCWeinshilboumRMHuman liver xanthine oxidase: nature and extent of individual variationClin Pharmacol Ther1991125066636721752110
  • TanSGelmanSWheatJKParksDACirculating xanthine oxidase in human ischemia reperfusionSouth Med J19958844794827716606
  • PesonenEJLinderNRaivioKOSarnestoALapattoRHockerstedtKCirculating xanthine oxidase and neutrophil activation during human liver transplantationGastroenterology19981145100910159558291
  • SpiekermannSLandmesserUDikalovSBredtMGamezGTatgeHElectron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilationCirculation2003107101383138912642358
  • de JongJWSchoemakerRGde JongeRBernocchiPKeijzerEHarrisonREnhanced expression and activity of xanthine oxidoreductase in the failing heartJ Mol Cell Cardiol200032112083208911040111
  • RadiRRubboHBushKFreemanBAXanthine Oxidase Binding to Glycosaminoglycans: Kinetics and Superoxide Dismutase Interactions of Immobilized Xanthine Oxidase-Heparin ComplexesArch Biochem Biophys199733911251359056242
  • PanusPCWrightSAChumleyPHRadiRFreemanBAThe contribution of vascular endothelial xanthine dehydrogenase/oxidase to oxygen-mediated cell injuryArch Biochem Biophys199229426957021567225
  • LandmesserUSpiekermannSDikalovSTatgeHWilkeRKohlerCVascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutaseCirculation2002106243073307812473554
  • PossWBHuecksteadtTPPanusPCFreemanBAHoidalJRRegulation of xanthine dehydrogenase and xanthine oxidase activity by hypoxiaAm J Physiol.1996270(6 Pt 1):L941L9468764218
  • ZweierJLKuppusamyPLuttyGAMeasurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissuesProc Natl Acad Sci U S A19888511404640502836868
  • DoehnerWAnkerSDUric acid in chronic heart failureSemin Nephrol2005251616615660337
  • PrasadKKalraJBharadwajLCardiac depressant effects of oxygen free radicalsAngiology19934442572708457076
  • BaldusSKosterRChumleyPHeitzerTRudolphVOstadMAOxypurinol improves coronary and peripheral endothelial function in patients with coronary artery diseaseFree Radic Biol Med20053991184119016214034
  • YiginerOOzcelikFInancTAparciMOzmenNCingozbayBYAllopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndromeClin Res Cardiol200897533434018330493
  • ButlerRMorrisADBelchJJHillAStruthersADAllopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertensionHypertension200035374675110720589
  • EngberdingNSpiekermannSSchaeferAHeinekeAWienckeAMullerMAllopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?Circulation2004110152175217915466649
  • SistoTPaajanenHMetsa-KetelaTHarmoinenANordbackITarkkaMPretreatment with antioxidants and allopurinol diminishes cardiac onset events in coronary artery bypass graftingAnn Thorac Surg1995596151915237771834
  • CardilloCKilcoyneCMCannonRO3rdQuyyumiAAPanzaJAXanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patientsHypertension199730(1 Pt 1):57639231821
  • DoehnerWSchoeneNRauchhausMLeyva-LeonFPavittDVReaveleyDAEffects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studiesCirculation2002105222619262412045167
  • FarquharsonCAJButlerRHillABelchJJFStruthersADAllopurinol improves endothelial dysfunction in chronic heart failureCirculation2002106222122612105162
  • GavinADStruthersADAllopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failureHeart200591674975315894768
  • GeorgeJCarrEDaviesJBelchJJFStruthersAHigh-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acidCirculation2006114232508251617130343
  • JamiesonNVLindellSSundbergRSouthardJHBelzerFOAn analysis of the components in UW solution using the isolated perfused rabbit liverTransplantation19884645125163176157
  • JohnsonWDKayserKLBrenowitzJBSaediSFA randomized controlled trial of allopurinol in coronary bypass surgeryAm Heart J1991121(1 Pt 1):20241985364
  • RashidMAWilliam-OlssonGInfluence of allopurinol on cardiac complications in open heart operationsAnn Thorac Surg19915211271302069440
  • ParmleyLFMuftiAGDowneyJMAllopurinol therapy of ischemic heart disease with infarct extensionCan J Cardiol1992832802861576562
  • KaliakinIEMit’kinAF[Effects of allopurinol on uric acid metabolism and lipid peroxidation in ischemic heart disease patients with stable angina]Kardiologiia199333215178084119
  • CoghlanJGFlitterWDCluttonSMPandaRDalyRWrightGAllopurinol pretreatment improves postoperative recovery and reduces lipid peroxidation in patients undergoing coronary artery bypass graftingJ Thorac Cardiovasc Surg199410712482568283893
  • TaggartDPYoungVHooperJKempMWalesbyRMageePLack of cardioprotective efficacy of allopurinol in coronary artery surgeryBr Heart J19947121771818130028
  • YamazakiISomaTIchikawaYIwaiYKondoJMatsumotoA[Usefulness of allopurinol for prevention of myocardial reperfusion injury in open heart surgery]Nippon Kyobu Geka Gakkai Zasshi199543126317884257
  • CastelliPCondemiAMBrambillascaCFundaroPBottaMLemmaMImprovement of cardiac function by allopurinol in patients undergoing cardiac surgeryJ Cardiovasc Pharmacol19952511191257723340
  • CoetzeeARoussouwGMacgregorLFailure of allopurinol to improve left ventricular stroke work after cardiopulmonary bypass surgeryJ Cardiothorac Vasc Anesth19961056276338841871
  • GuanWOsanaiTKamadaTHanadaHIshizakaHOnoderaHEffect of allopurinol pretreatment on free radical generation after primary coronary angioplasty for acute myocardial infarctionJ Cardiovasc Pharmacol200341569970512717099
  • MunkresKDAgeing of Neurospora crassa IV. Induction of senescence in wild type by dietary amino acid analogs and reversal by antioxidants and membrane stabilizersMech Ageing Dev1976531711917715
  • CaiHHarrisonDGEndothelial dysfunction in cardiovascular diseases: the role of oxidant stressCirc Res2000871084084411073878
  • DeanfieldJEHalcoxJPRabelinkTJEndothelial function and dysfunction: testing and clinical relevanceCirculation2007115101285129517353456
  • AmadoLCSaliarisAPRajuSVLehrkeSSt JohnMXieJXanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failureJ Mol Cell Cardiol200539353153615963530
  • DasDKEngelmanRMClementROtaniHPrasadMRRaoPSRole of xanthine oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvageBiochem Biophys Res Commun198714813143192823807
  • HoeyBMButlerJHalliwellBOn the specificity of allopurinol and oxypurinol as inhibitors of xanthine oxidase. A pulse radiolysis determination of rate constants for reaction of allopurinol and oxypurinol with hydroxyl radicalsFree Radic Res Commun1988442592632852627
  • RicardoSDBertramJFRyanGBPodocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinolExp Nephrol1995352702797583048
  • KeshavarzianAMorganGSedghiSGordonJHDoriaMRole of reactive oxygen metabolites in experimental colitisGut19903177867902164491
  • AugustinAJBokerTBlumenroderSHLutzJSpitznasMFree radical scavenging and antioxidant activity of allopurinol and oxypurinol in experimental lens-induced uveitisInvest Ophthalmol Vis Sci19943511389739047928187
  • KnightTRKurtzABajtMLHinsonJAJaeschkeHVascular and hepatocellular peroxynitrite formation during acetaminophen toxicity: role of mitochondrial oxidant stressToxicol Sci200162221222011452133
  • MalkielSHar-elRSchwalbHUretzkyGBormanJBChevionMInteraction between allopurinol and copper: possible role in myocardial protectionFree Radic Res Commun19931817158349148
  • NishizawaJNakaiAMatsudaKKomedaMBanTNagataKReactive oxygen species play an important role in the activation of heat shock factor 1 in ischemic-reperfused heartCirculation199999793494110027818
  • GrangerDNBenoitJNSuzukiMGrishamMBLeukocyte adherence to venular endothelium during ischemia-reperfusionAm J Physiol1989257(5 Pt 1):G683G6882596604
  • KittlesonMMHareJMXanthine oxidase inhibitors: an emerging class of drugs for heart failureEur Heart J200526151458146015917281
  • EkelundUEHarrisonRWShokekOThakkarRNTuninRSSenzakiHIntravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failureCirc Res199985543744510473673
  • SaavedraWFPaolocciNSt JohnMESkafMWStewartGCXieJSImbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heartCirc Res2002 22;90329730411861418
  • NaumovaAVChackoVPOuwerkerkRStullLMarbanEWeissRGXanthine oxidase inhibitors improve energetics and function after infarction in failing mouse heartsAm J Physiol Heart Circ Physiol20062902H837H84316183726
  • StullLBLeppoMKSzwedaLGaoWDMarbanEChronic treatment with allopurinol boosts survival and cardiac contractility in murine postischemic cardiomyopathyCirc Res200495101005101115499028
  • KhanSALeeKMinhasKMGonzalezDRRajuSVTejaniADNeuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction couplingProc Natl Acad Sci U S A200410145159441594815486091
  • PerezNGGaoWDMarbanENovel myofilament Ca2+-sensitizing property of xanthine oxidase inhibitorsCirc Res19988344234309721699
  • CappolaTPKassDANelsonGSBergerRDRosasGOKobeissiZAAllopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathyCirculation2001104202407241111705816